Dexamethasone in cryptococcus gattii central nervous system infection

46Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Clinical outcomes were reviewed for 4 patients with Cryptococcus gattii central nervous system infection who received dexamethasone for the treatment of persisting mental status abnormalities and focal lesions on brain scan despite culture- negative cerebrospinal fluid and the management of intra-cranial pressure. Favorable clinical responses were observed in 3 patients. Although corticosteroids are not recommended for the treatment of cryptococcal meningitis, these observations suggest that dexamethasone should be further evaluated in this subset of patients. © 2009 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Phillips, P., Chapman, K., Sharp, M., Harrison, P., Vortel, J., Steiner, T., & Bowie, W. (2009). Dexamethasone in cryptococcus gattii central nervous system infection. Clinical Infectious Diseases, 49(4), 591–595. https://doi.org/10.1086/603554

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free